MiR-203 is an anti-obese microRNA by targeting apical sodium-dependent bile acid transporter

Xin Liu,Feiran Cheng,Xue Bai,Tong Zhao,Limin Zhao,Lei Wang,Mingqi Li,Xianxian Wu,Xiaohui Chen,Pingping Tang,Mengxue Wang,Lintong Jiang,Chaoqi Yan,Fenghua Pei,Xu Gao,Ning Ma,Baofeng Yang,Yong Zhang
DOI: https://doi.org/10.1016/j.isci.2022.104708
IF: 5.8
2022-08-19
iScience
Abstract:Obesity is characterized by excessive fat deposition within the body. Bile acids (BA) are important regulators for controlling the absorption of lipid. Here we show that miR-203 exerts weight-loss and lipid-lowering effects by increasing total BA excretion in obese rodents. miR-203 overexpression transgenic mice are resistant to high-fat diet (HFD)-induced obesity and dyslipidemia. Moreover, the knockdown of miR-203 deteriorates metabolic disorders. ASBT plays important role in regulating BA homeostasis and is a direct target of miR-203. In human intestinal epithelial cells, overexpression of miR-203 decreases the cellular uptake of BA by inhibiting ASBT. Furthermore, TCF7L2 is downregulated in obese mice and acts as a transcription factor of miR-203. The ASBT mRNA level was positively correlated with the body mass index (BMI) of population, while the miR-203 level was negatively associated with BMI. Taken together, these data suggest miR-203 could be a new therapeutic BA regulator for obesity and dyslipidemia.
multidisciplinary sciences
What problem does this paper attempt to address?